| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.852 | 0.002 | 0.852 | Alcohol oxidase inhibitor | 0.076 0.026 CID_154699902 | ||
| 0.832 | 0.002 | 0.832 | Alpha-N-acetylglucosaminidase inhibitor | 0.81 0.002 CID_154699902 | ||
| 0.701 | 0.002 | 0.701 | GABA aminotransferase inhibitor | 0.476 0.003 CID_154699902 | ||
| 0.704 | 0.008 | 0.704 | Aldehyde oxidase inhibitor | |||
| 0.648 | 0.002 | 0.648 | Glutamate dehydrogenase inhibitor | 0.254 0.007 CID_154699902 | ||
| 0.645 | 0.003 | 0.645 | Porphobilinogen synthase inhibitor | |||
| 0.624 | 0.002 | 0.632 | Triose-phosphate isomerase inhibitor | 0.632 0.002 CID_154699902 | CID_154699902 | |
| 0.635 | 0.014 | 0.796 | Cholesterol antagonist | 0.796 0.004 CID_154699902 | CID_154699902 | |
| 0.576 | 0.003 | 0.576 | GABA C receptor agonist | |||
| 0.561 | 0.003 | 0.561 | Cystathionine beta-synthase inhibitor | 0.317 0.008 CID_154699902 | ||
| 0.546 | 0.002 | 0.546 | Keratolytic | 0.182 0.01 CID_154699902 | ||
| 0.539 | 0.002 | 0.539 | Ferrochelatase inhibitor | |||
| 0.532 | 0.024 | 0.532 | 5 Hydroxytryptamine release inhibitor | 0.416 0.068 CID_154699902 | ||
| 0.508 | 0.012 | 0.508 | Superoxide dismutase inhibitor | |||
| 0.498 | 0.003 | 0.498 | Alcohol dehydrogenase inhibitor | 0.241 0.008 CID_154699902 | ||
| 0.481 | 0.005 | 0.481 | Amyloid beta precursor protein antagonist | 0.154 0.097 CID_154699902 | ||
| 0.489 | 0.033 | 0.501 | Histamine release inhibitor | 0.501 0.029 CID_154699902 | CID_154699902 | |
| 0.445 | 0.004 | 0.445 | Succinate dehydrogenase inhibitor | 0.161 0.094 CID_154699902 | ||
| 0.452 | 0.011 | 0.452 | Calcium channel activator | 0.272 0.121 CID_154699902 | ||
| 0.443 | 0.005 | 0.443 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.44 | 0.003 | 0.44 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.41 0.004 CID_154699902 | ||
| 0.433 | 0.007 | 0.433 | Protein-tyrosine phosphatase inhibitor | 0.336 0.014 CID_154699902 | ||
| 0.428 | 0.004 | 0.428 | 3C-like protease (Human coronavirus) inhibitor | 0.143 0.113 CID_154699902 | ||
| 0.47 | 0.049 | 0.47 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.43 | 0.01 | 0.43 | Sodium/bile acid cotransporter inhibitor | 0.319 0.063 CID_154699902 | ||
| 0.422 | 0.005 | 0.487 | UDP-glucose 4-epimerase inhibitor | 0.487 0.003 CID_154699902 | CID_154699902 | |
| 0.423 | 0.005 | 0.423 | Aldehyde dehydrogenase inhibitor | 0.259 0.017 CID_154699902 | ||
| 0.421 | 0.011 | 0.421 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.395 | 0.003 | 0.395 | Electrolyte absorption antagonist | |||
| 0.395 | 0.004 | 0.395 | Carbonic anhydrase XV inhibitor | |||
| 0.448 | 0.058 | 0.66 | Antibacterial | 0.66 0.012 CID_154699902 | CID_154699902 | |
| 0.408 | 0.02 | 0.536 | DNA synthesis inhibitor | 0.536 0.011 CID_154699902 | CID_154699902 | |
| 0.404 | 0.02 | 0.404 | Peroxidase inhibitor | |||
| 0.377 | 0.002 | 0.377 | Biliverdin reductase inhibitor | 0.153 0.009 CID_154699902 | ||
| 0.392 | 0.021 | 0.392 | Transcription factor STAT inhibitor | 0.227 0.105 CID_154699902 | ||
| 0.374 | 0.003 | 0.374 | Mannose-6-phosphate isomerase inhibitor | 0.367 0.004 CID_154699902 | ||
| 0.362 | 0.001 | 0.362 | NMDA 2D receptor antagonist | 0.113 0.004 CID_154699902 | ||
| 0.415 | 0.055 | 0.415 | GABA C receptor rho-3 antagonist | |||
| 0.37 | 0.016 | 0.37 | MAP kinase kinase 2 inhibitor | |||
| 0.345 | 0.005 | 0.345 | Adenylate kinase inhibitor | 0.224 0.012 CID_154699902 | ||
| 0.341 | 0.008 | 0.341 | Protein kinase (CK2) alpha inhibitor | |||
| 0.347 | 0.015 | 0.347 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.375 | 0.044 | 0.581 | Vasodilator, coronary | 0.581 0.009 CID_154699902 | CID_154699902 | |
| 0.332 | 0.002 | 0.332 | Glutamate (mGluR3) antagonist | 0.041 0.019 CID_154699902 | ||
| 0.329 | 0.005 | 0.329 | NMDA receptor antagonist | |||
| 0.324 | 0.002 | 0.324 | Aconitate hydratase inhibitor | |||
| 0.325 | 0.006 | 0.49 | NADH dehydrogenase inhibitor | 0.49 0.003 CID_154699902 | CID_154699902 | |
| 0.351 | 0.033 | 0.351 | Pyruvate kinase inhibitor | |||
| 0.35 | 0.034 | 0.35 | Amyloid beta aggregation inhibitor | 0.32 0.041 CID_154699902 | ||
| 0.311 | 0.004 | 0.311 | Creatine kinase inhibitor | |||
| 0.364 | 0.06 | 0.739 | Antithrombotic | 0.739 0.006 CID_154699902 | CID_154699902 | |
| 0.308 | 0.005 | 0.308 | NMDA 2 receptor antagonist | |||
| 0.308 | 0.006 | 0.308 | Protein kinase (CK2) inhibitor | |||
| 0.305 | 0.003 | 0.305 | Prostaglandin F2 alpha antagonist | 0.102 0.011 CID_154699902 | ||
| 0.309 | 0.01 | 0.31 | Hexokinase inhibitor | 0.31 0.01 CID_154699902 | CID_154699902 | |
| 0.369 | 0.071 | 0.76 | Transcription factor NF kappa B inhibitor | 0.76 0.016 CID_154699902 | CID_154699902 | |
| 0.3 | 0.003 | 0.3 | Glutamate (mGluR group III) antagonist | |||
| 0.299 | 0.002 | 0.299 | Glutamate (mGluR4) antagonist | |||
| 0.297 | 0.002 | 0.297 | D-Ala-D-Ala ligase inhibitor | 0.09 0.045 CID_154699902 | ||
| 0.301 | 0.011 | 0.301 | Protein-tyrosine phosphatase 1B inhibitor | 0.291 0.011 CID_154699902 | ||
| 0.383 | 0.093 | 0.383 | Calcium channel L-type activator | |||
| 0.295 | 0.006 | 0.418 | ATPase inhibitor | 0.418 0.003 CID_154699902 | CID_154699902 | |
| 0.295 | 0.009 | 0.295 | MAP kinase kinase inhibitor | |||
| 0.292 | 0.007 | 0.292 | Histidine decarboxylase inhibitor | |||
| 0.328 | 0.047 | 0.444 | DNA damaging | 0.444 0.02 CID_154699902 | CID_154699902 | |
| 0.286 | 0.007 | 0.286 | Aminoacyl-tRNA synthetase inhibitor | 0.13 0.025 CID_154699902 | ||
| 0.283 | 0.005 | 0.36 | Photosensitizer | 0.36 0.003 CID_154699902 | CID_154699902 | |
| 0.293 | 0.018 | 0.419 | Protein kinase stimulant | 0.419 0.007 CID_154699902 | CID_154699902 | |
| 0.32 | 0.046 | 0.545 | Antiamyloidogenic | 0.545 0.012 CID_154699902 | CID_154699902 | |
| 0.284 | 0.011 | 0.284 | Glutamate receptor antagonist | |||
| 0.277 | 0.004 | 0.277 | Glutamate decarboxylase inhibitor | |||
| 0.274 | 0.003 | 0.274 | DOPA decarboxylase inhibitor | 0.095 0.087 CID_154699902 | ||
| 0.272 | 0.003 | 0.272 | Kainate receptor antagonist | |||
| 0.277 | 0.011 | 0.277 | Cathepsin H inhibitor | 0.113 0.085 CID_154699902 | ||
| 0.27 | 0.005 | 0.27 | MAP kinase kinase 5 inhibitor | 0.158 0.123 CID_154699902 | ||
| 0.265 | 0.003 | 0.265 | Kainate receptor 5 antagonist | |||
| 0.266 | 0.004 | 0.266 | NMDA 2C receptor antagonist | |||
| 0.261 | 0.004 | 0.261 | NMDA receptor subunit 3A antagonist | |||
| 0.26 | 0.004 | 0.26 | NMDA receptor subunit 3B antagonist | |||
| 0.259 | 0.006 | 0.259 | Uric acid excretion stimulant | 0.187 0.015 CID_154699902 | ||
| 0.297 | 0.06 | 0.297 | Insulysin inhibitor | |||
| 0.236 | 0.003 | 0.236 | Kainate receptor 1 antagonist | |||
| 0.234 | 0.003 | 0.234 | AMPA 4 receptor antagonist | |||
| 0.28 | 0.05 | 0.354 | Cyclic AMP phosphodiesterase inhibitor | 0.354 0.025 CID_154699902 | CID_154699902 | |
| 0.38 | 0.152 | 0.855 | Antiinflammatory | 0.855 0.009 CID_154699902 | CID_154699902 | |
| 0.246 | 0.019 | 0.246 | Adenylate cyclase inhibitor | 0.175 0.032 CID_154699902 | ||
| 0.23 | 0.004 | 0.23 | Acyl-CoA dehydrogenase inhibitor | 0.088 0.019 CID_154699902 | ||
| 0.359 | 0.134 | 0.738 | Apoptosis agonist | 0.738 0.024 CID_154699902 | CID_154699902 | |
| 0.296 | 0.072 | 0.504 | Spasmolytic | 0.504 0.022 CID_154699902 | CID_154699902 | |
| 0.255 | 0.032 | 0.255 | Lipocortins synthesis antagonist | 0.136 0.128 CID_154699902 | ||
| 0.225 | 0.004 | 0.225 | NMDA 2A receptor antagonist | |||
| 0.228 | 0.01 | 0.228 | Carbonic anhydrase VI inhibitor | 0.104 0.037 CID_154699902 | ||
| 0.277 | 0.061 | 0.366 | Interleukin agonist | 0.366 0.025 CID_154699902 | CID_154699902 | |
| 0.301 | 0.085 | 0.63 | Apoptosis antagonist | 0.63 0.007 CID_154699902 | CID_154699902 | |
| 0.218 | 0.003 | 0.218 | Fumarate hydratase inhibitor | 0.058 0.011 CID_154699902 | ||
| 0.217 | 0.004 | 0.217 | Purinergic P2X2 antagonist | 0.125 0.019 CID_154699902 | ||
| 0.228 | 0.016 | 0.228 | Aminopeptidase B inhibitor | |||
| 0.242 | 0.032 | 0.242 | Diuretic | 0.198 0.045 CID_154699902 | ||
| 0.219 | 0.009 | 0.219 | MAP3K9 inhibitor | |||
| 0.225 | 0.017 | 0.225 | Interleukin 4 antagonist | 0.199 0.023 CID_154699902 | ||
| 0.213 | 0.006 | 0.213 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.21 | 0.004 | 0.21 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.145 0.008 CID_154699902 | ||
| 0.212 | 0.007 | 0.212 | Argininosuccinate synthase inhibitor | 0.07 0.03 CID_154699902 | ||
| 0.208 | 0.004 | 0.208 | Glycine receptor agonist | 0.137 0.009 CID_154699902 | ||
| 0.206 | 0.005 | 0.206 | MAP kinase kinase 1 inhibitor | |||
| 0.204 | 0.004 | 0.204 | NMDA receptor agonist | |||
| 0.263 | 0.064 | 0.263 | Gastrin inhibitor | |||
| 0.202 | 0.004 | 0.202 | TRPM8 blocker | |||
| 0.201 | 0.004 | 0.201 | Ca2+-transporting ATPase inhibitor | 0.181 0.007 CID_154699902 | ||
| 0.207 | 0.01 | 0.263 | Phosphofructokinase-1 inhibitor | 0.263 0.007 CID_154699902 | CID_154699902 | |
| 0.209 | 0.013 | 0.209 | Carbonic anhydrase XIII inhibitor | 0.108 0.034 CID_154699902 | ||
| 0.21 | 0.014 | 0.21 | Catalase inhibitor | |||
| 0.199 | 0.004 | 0.199 | Plasminogen activator inhibitor antagonist | |||
| 0.239 | 0.048 | 0.239 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.154 0.14 CID_154699902 | ||
| 0.196 | 0.007 | 0.196 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.077 0.069 CID_154699902 | ||
| 0.261 | 0.075 | 0.261 | Transcription factor STAT3 inhibitor | |||
| 0.194 | 0.01 | 0.194 | Caspase 3 inhibitor | |||
| 0.192 | 0.01 | 0.192 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.23 | 0.052 | 0.463 | Non-steroidal antiinflammatory agent | 0.463 0.008 CID_154699902 | CID_154699902 | |
| 0.21 | 0.031 | 0.21 | CDC-like kinase 1 inhibitor | |||
| 0.187 | 0.009 | 0.187 | Transcription factor STAT6 inhibitor | |||
| 0.221 | 0.043 | 0.221 | Histone acetyltransferase inhibitor | |||
| 0.188 | 0.01 | 0.188 | GABA C receptor rho-1 antagonist | |||
| 0.184 | 0.008 | 0.184 | Aminopeptidase I inhibitor | |||
| 0.245 | 0.069 | 0.245 | Calpain inhibitor | |||
| 0.189 | 0.015 | 0.189 | GABA C receptor antagonist | |||
| 0.193 | 0.021 | 0.261 | Xanthine oxidase inhibitor | 0.261 0.011 CID_154699902 | CID_154699902 | |
| 0.231 | 0.059 | 0.295 | DNA methylase inhibitor | 0.295 0.029 CID_154699902 | CID_154699902 | |
| 0.241 | 0.071 | 0.241 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.201 | 0.032 | 0.201 | Arachidonic acid antagonist | 0.125 0.119 CID_154699902 | ||
| 0.21 | 0.041 | 0.483 | Amylase inhibitor | 0.483 0.006 CID_154699902 | CID_154699902 | |
| 0.173 | 0.005 | 0.173 | Xanthine dehydrogenase inhibitor | 0.08 0.024 CID_154699902 | ||
| 0.316 | 0.149 | 0.773 | Cyclophilin D inhibitor | 0.773 0.008 CID_154699902 | CID_154699902 | |
| 0.169 | 0.005 | 0.232 | Glycine receptor antagonist | 0.232 0.003 CID_154699902 | CID_154699902 | |
| 0.165 | 0.004 | 0.165 | Nicotinic acid receptor agonist | |||
| 0.162 | 0.003 | 0.162 | Glutamate (mGluR7) antagonist | |||
| 0.177 | 0.02 | 0.196 | Mucolytic | 0.196 0.014 CID_154699902 | CID_154699902 | |
| 0.165 | 0.007 | 0.165 | Prostaglandin E2 antagonist | |||
| 0.161 | 0.004 | 0.161 | NMDA receptor glycine site agonist | |||
| 0.157 | 0.003 | 0.157 | Retinoic acid beta receptor agonist | |||
| 0.198 | 0.045 | 0.198 | Phospholipase C inhibitor | 0.146 0.115 CID_154699902 | ||
| 0.16 | 0.009 | 0.16 | Ornithine carbamoyltransferase inhibitor | 0.055 0.035 CID_154699902 | ||
| 0.154 | 0.003 | 0.154 | Retinoic acid alpha receptor agonist | 0.038 0.03 CID_154699902 | ||
| 0.16 | 0.011 | 0.16 | Histamine N-methyltransferase inhibitor | |||
| 0.228 | 0.08 | 0.852 | Angiogenesis stimulant | 0.852 0.003 CID_154699902 | CID_154699902 | |
| 0.153 | 0.007 | 0.153 | Purinergic P2X1 antagonist | 0.074 0.028 CID_154699902 | ||
| 0.175 | 0.029 | 0.175 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.148 | 0.003 | 0.148 | MDM2 inhibitor | |||
| 0.183 | 0.038 | 0.304 | Cell wall synthesis inhibitor | 0.304 0.01 CID_154699902 | CID_154699902 | |
| 0.203 | 0.059 | 0.203 | Dual specificity phosphatase 3 inhibitor | |||
| 0.15 | 0.008 | 0.151 | ATPase (Vacuolar H+) inhibitor | 0.151 0.007 CID_154699902 | CID_154699902 | |
| 0.226 | 0.084 | 0.226 | Dyrk kinase inhibitor | |||
| 0.218 | 0.076 | 0.218 | RNA-directed DNA polymerase inhibitor | 0.17 0.152 CID_154699902 | ||
| 0.146 | 0.005 | 0.146 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.156 | 0.015 | 0.169 | Carbonic anhydrase inhibitor | 0.169 0.013 CID_154699902 | CID_154699902 | |
| 0.146 | 0.006 | 0.146 | Dopamine transporter inhibitor | |||
| 0.155 | 0.015 | 0.16 | Thioredoxin inhibitor | 0.16 0.014 CID_154699902 | CID_154699902 | |
| 0.145 | 0.005 | 0.145 | Sigma 1 receptor antagonist | |||
| 0.145 | 0.005 | 0.145 | Leukotriene A4 hydrolase inhibitor | |||
| 0.181 | 0.041 | 0.181 | GABA C receptor rho-2 antagonist | |||
| 0.162 | 0.024 | 0.162 | Carbonic anhydrase III inhibitor | |||
| 0.177 | 0.039 | 0.177 | Neurotrophic factor | |||
| 0.141 | 0.003 | 0.141 | Dihydroorotate oxidase inhibitor | |||
| 0.142 | 0.005 | 0.142 | Phosphodiesterase 1C inhibitor | |||
| 0.16 | 0.023 | 0.263 | DNA repair enzyme inhibitor | 0.263 0.005 CID_154699902 | CID_154699902 | |
| 0.174 | 0.038 | 0.174 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.138 | 0.002 | 0.138 | Nicotinic acid receptor 2 antagonist | |||
| 0.139 | 0.003 | 0.139 | Retinoid X alpha receptor agonist | |||
| 0.146 | 0.012 | 0.146 | Ornithine decarboxylase inhibitor | 0.075 0.073 CID_154699902 | ||
| 0.183 | 0.049 | 0.26 | Interferon gamma antagonist | 0.26 0.027 CID_154699902 | CID_154699902 | |
| 0.164 | 0.03 | 0.397 | Expectorant | 0.397 0.005 CID_154699902 | CID_154699902 | |
| 0.136 | 0.003 | 0.136 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | |||
| 0.136 | 0.003 | 0.136 | AICAR transformylase inhibitor | 0.055 0.018 CID_154699902 | ||
| 0.141 | 0.008 | 0.141 | Autotaxin inhibitor | |||
| 0.143 | 0.01 | 0.143 | Prostaglandin EP2 antagonist | |||
| 0.137 | 0.005 | 0.137 | Thromboxane antagonist | 0.047 0.045 CID_154699902 | ||
| 0.135 | 0.003 | 0.135 | Retinoic acid receptor agonist | |||
| 0.136 | 0.004 | 0.136 | Nicotinic acid receptor 2 agonist | |||
| 0.203 | 0.073 | 0.249 | Anesthetic general | 0.249 0.051 CID_154699902 | CID_154699902 | |
| 0.134 | 0.004 | 0.134 | Glutamate (mGluR6) antagonist | |||
| 0.132 | 0.003 | 0.132 | NMDA receptor glycine site antagonist | |||
| 0.158 | 0.03 | 0.158 | Heat shock protein 70 antagonist | 0.133 0.107 CID_154699902 | ||
| 0.152 | 0.025 | 0.152 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.131 | 0.004 | 0.131 | Thromboxane synthase inhibitor | |||
| 0.165 | 0.038 | 0.165 | Farnesoid X receptor antagonist | |||
| 0.13 | 0.004 | 0.13 | Kainate receptor 2 antagonist | |||
| 0.23 | 0.105 | 0.552 | Immunostimulant | 0.552 0.022 CID_154699902 | CID_154699902 | |
| 0.169 | 0.044 | 0.169 | MAP kinase 3 inhibitor | |||
| 0.205 | 0.081 | 0.205 | Nitric-oxide synthase stimulant | 0.205 0.08 CID_154699902 | ||
| 0.127 | 0.003 | 0.127 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.161 | 0.039 | 0.27 | Cyclooxygenase 3 inhibitor | 0.27 0.007 CID_154699902 | CID_154699902 | |
| 0.131 | 0.01 | 0.159 | Neuraminidase (influenza) inhibitor | 0.159 0.007 CID_154699902 | CID_154699902 | |
| 0.147 | 0.026 | 0.598 | Beta glucuronidase inhibitor | 0.598 0.003 CID_154699902 | CID_154699902 | |
| 0.128 | 0.009 | 0.239 | Phosphorylase inhibitor | 0.239 0.004 CID_154699902 | CID_154699902 | |
| 0.124 | 0.005 | 0.124 | Thromboxane A2 antagonist | 0.049 0.037 CID_154699902 | ||
| 0.183 | 0.065 | 0.183 | Dual specificity phosphatase inhibitor | |||
| 0.131 | 0.013 | 0.131 | Bile acid receptor antagonist | 0.086 0.083 CID_154699902 | ||
| 0.195 | 0.078 | 0.195 | Death-associated protein kinase 3 inhibitor | |||
| 0.169 | 0.053 | 0.169 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.129 | 0.013 | 0.129 | Carbonic anhydrase I inhibitor | 0.098 0.019 CID_154699902 | ||
| 0.135 | 0.019 | 0.135 | Adrenaline agonist | |||
| 0.232 | 0.117 | 0.281 | Hypoxia-inducible factor 1 alpha inhibitor | 0.281 0.076 CID_154699902 | CID_154699902 | |
| 0.116 | 0.002 | 0.116 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.117 | 0.004 | 0.117 | RNA-directed RNA polymerase inhibitor | |||
| 0.125 | 0.012 | 0.125 | Carbonic anhydrase VB inhibitor | |||
| 0.17 | 0.059 | 0.17 | Phospholipase A2 inhibitor | |||
| 0.127 | 0.017 | 0.127 | Myeloperoxidase inhibitor | |||
| 0.156 | 0.046 | 0.156 | Anesthetic local | |||
| 0.153 | 0.043 | 0.153 | Cholesterol synthesis inhibitor | 0.099 0.088 CID_154699902 | ||
| 0.148 | 0.039 | 0.246 | Microtubule formation inhibitor | 0.246 0.01 CID_154699902 | CID_154699902 | |
| 0.128 | 0.019 | 0.128 | Cyclin B3 inhibitor | |||
| 0.123 | 0.014 | 0.123 | Carbonic anhydrase II inhibitor | 0.105 0.018 CID_154699902 | ||
| 0.127 | 0.019 | 0.127 | Glutathione S-transferase inhibitor | |||
| 0.118 | 0.01 | 0.118 | Beta 3 adrenoreceptor antagonist | |||
| 0.134 | 0.028 | 0.134 | Anabolic | 0.09 0.078 CID_154699902 | ||
| 0.124 | 0.019 | 0.124 | Histamine H2 receptor antagonist | |||
| 0.109 | 0.004 | 0.109 | Retinoid X receptor agonist | |||
| 0.127 | 0.024 | 0.127 | Phosphodiesterase I inhibitor | |||
| 0.109 | 0.006 | 0.109 | Phosphoglycerate kinase inhibitor | 0.051 0.013 CID_154699902 | ||
| 0.188 | 0.086 | 0.188 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.12 | 0.018 | 0.12 | Adenosine A3 receptor antagonist | 0.084 0.038 CID_154699902 | ||
| 0.129 | 0.029 | 0.129 | Androgen antagonist | |||
| 0.112 | 0.012 | 0.112 | Phosphodiesterase 1B inhibitor | |||
| 0.114 | 0.015 | 0.114 | Carbonic anhydrase stimulant | |||
| 0.11 | 0.012 | 0.113 | Neuraminidase inhibitor | 0.113 0.011 CID_154699902 | CID_154699902 | |
| 0.108 | 0.01 | 0.108 | AMPA receptor antagonist | |||
| 0.102 | 0.005 | 0.102 | HCV NS5B polymerase inhibitor | |||
| 0.101 | 0.004 | 0.101 | Adenine nucleotide translocase inhibitor | 0.09 0.006 CID_154699902 | ||
| 0.1 | 0.004 | 0.1 | Membrane dipeptidase inhibitor | |||
| 0.119 | 0.022 | 0.456 | Selectin antagonist | 0.456 0.003 CID_154699902 | CID_154699902 | |
| 0.099 | 0.003 | 0.099 | Kainate receptor agonist | 0.042 0.027 CID_154699902 | ||
| 0.119 | 0.024 | 0.119 | Somatostatin 1 agonist | |||
| 0.121 | 0.027 | 0.121 | Cathepsin G inhibitor | |||
| 0.122 | 0.028 | 0.122 | Interleukin 12 antagonist | 0.115 0.034 CID_154699902 | ||
| 0.111 | 0.018 | 0.111 | Carbamoyl phosphate synthetase inhibitor | 0.061 0.042 CID_154699902 | ||
| 0.141 | 0.048 | 0.25 | Beta amyloid protein antagonist | 0.25 0.009 CID_154699902 | CID_154699902 | |
| 0.175 | 0.084 | 0.608 | Hepatoprotectant | 0.608 0.004 CID_154699902 | CID_154699902 | |
| 0.183 | 0.092 | 0.183 | Insulin sensitizer | |||
| 0.193 | 0.103 | 0.653 | Free radical scavenger | 0.653 0.006 CID_154699902 | CID_154699902 | |
| 0.113 | 0.023 | 0.113 | Carbonic anhydrase V inhibitor | |||
| 0.141 | 0.053 | 0.141 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.092 | 0.004 | 0.092 | Retinoid X gamma receptor agonist | |||
| 0.092 | 0.004 | 0.092 | Retinoid X beta receptor agonist | |||
| 0.093 | 0.006 | 0.093 | AMPA 1 receptor antagonist | |||
| 0.11 | 0.023 | 0.11 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.131 | 0.044 | 0.131 | Chelator | |||
| 0.104 | 0.017 | 0.104 | Dopamine uptake inhibitor | |||
| 0.108 | 0.022 | 0.108 | Carbonic anhydrase VA inhibitor | |||
| 0.091 | 0.004 | 0.091 | AMPA 3 receptor antagonist | |||
| 0.114 | 0.028 | 0.114 | Macrophage migration inhibitory factor inhibitor | |||
| 0.12 | 0.035 | 0.12 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.108 | 0.026 | 0.108 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.087 | 0.005 | 0.087 | Thymidylate synthase inhibitor | |||
| 0.227 | 0.147 | 0.375 | Vasodilator, peripheral | 0.375 0.064 CID_154699902 | CID_154699902 | |
| 0.098 | 0.017 | 0.098 | Beta adrenoreceptor antagonist | |||
| 0.115 | 0.035 | 0.115 | Potassium channel activator | |||
| 0.096 | 0.016 | 0.096 | CDK4/cyclin D1 inhibitor | |||
| 0.116 | 0.035 | 0.116 | Protein kinase C zeta inhibitor | 0.086 0.074 CID_154699902 | ||
| 0.097 | 0.018 | 0.097 | Prostaglandin antagonist | |||
| 0.142 | 0.062 | 0.142 | Nav1.2 sodium channel blocker | |||
| 0.09 | 0.011 | 0.09 | Sphingosine kinase 2 inhibitor | |||
| 0.097 | 0.018 | 0.097 | GABA B receptor agonist | |||
| 0.104 | 0.025 | 0.184 | Interferon agonist | 0.184 0.007 CID_154699902 | CID_154699902 | |
| 0.13 | 0.052 | 0.13 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.128 | 0.05 | 0.128 | TRPA1 agonist | |||
| 0.084 | 0.006 | 0.084 | Glutamate (mGluR group II) antagonist | |||
| 0.09 | 0.013 | 0.09 | Beta 1 adrenoreceptor antagonist | |||
| 0.095 | 0.018 | 0.095 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.084 | 0.007 | 0.084 | Urate transporter 1 inhibitor | |||
| 0.085 | 0.008 | 0.109 | Squalene epoxidase inhibitor | 0.109 0.005 CID_154699902 | CID_154699902 | |
| 0.097 | 0.021 | 0.111 | Carbonic anhydrase IX inhibitor | 0.111 0.018 CID_154699902 | CID_154699902 | |
| 0.08 | 0.004 | 0.08 | Glutamate (mGluR8) agonist | |||
| 0.087 | 0.011 | 0.087 | 5-Alpha-reductase inhibitor | |||
| 0.081 | 0.006 | 0.213 | Heparanase inhibitor | 0.213 0.002 CID_154699902 | CID_154699902 | |
| 0.088 | 0.013 | 0.088 | Phosphodiesterase 1A inhibitor | |||
| 0.076 | 0.001 | 0.076 | Complement factor 1r inhibitor | 0.046 0.003 CID_154699902 | ||
| 0.134 | 0.059 | 0.136 | Vanilloid 1 agonist | 0.136 0.056 CID_154699902 | CID_154699902 | |
| 0.101 | 0.027 | 0.101 | Caspase 7 inhibitor | |||
| 0.161 | 0.087 | 0.161 | LIM domain kinase 1 inhibitor | |||
| 0.083 | 0.01 | 0.083 | Carbonic anhydrase IV inhibitor | |||
| 0.076 | 0.004 | 0.076 | Uridine phosphorylase inhibitor | 0.069 0.004 CID_154699902 | ||
| 0.095 | 0.025 | 0.095 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.195 | 0.125 | 0.195 | 5 Hydroxytryptamine release stimulant | 0.174 0.148 CID_154699902 | ||
| 0.078 | 0.008 | 0.078 | Potassium channel (Inward rectifier) activator | 0.049 0.037 CID_154699902 | ||
| 0.075 | 0.005 | 0.075 | Purinergic P2Y14 antagonist | |||
| 0.091 | 0.022 | 0.091 | MAP kinase kinase 7 inhibitor | |||
| 0.077 | 0.009 | 0.115 | Glucose-6-phosphate isomerase inhibitor | 0.115 0.004 CID_154699902 | CID_154699902 | |
| 0.076 | 0.008 | 0.076 | Potassium channel (ATP-sensitive) activator | 0.047 0.035 CID_154699902 | ||
| 0.134 | 0.067 | 0.134 | NADPH oxidase inhibitor | |||
| 0.076 | 0.009 | 0.076 | Dihydroorotase inhibitor | |||
| 0.071 | 0.005 | 0.071 | Guanylate cyclase inhibitor | 0.061 0.011 CID_154699902 | ||
| 0.086 | 0.02 | 0.137 | Interferon inducer | 0.137 0.005 CID_154699902 | CID_154699902 | |
| 0.142 | 0.076 | 0.142 | Adenylate cyclase stimulant | 0.133 0.096 CID_154699902 | ||
| 0.072 | 0.006 | 0.072 | GABA uptake inhibitor | |||
| 0.069 | 0.005 | 0.069 | Protein kinase (CK2) beta inhibitor | |||
| 0.072 | 0.008 | 0.072 | GABA B receptor antagonist | |||
| 0.074 | 0.01 | 0.191 | Mannosidase inhibitor | 0.191 0.003 CID_154699902 | CID_154699902 | |
| 0.169 | 0.105 | 0.169 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.077 | 0.013 | 0.077 | Beta 2 adrenoreceptor antagonist | |||
| 0.086 | 0.023 | 0.12 | Carbonic anhydrase XII inhibitor | 0.12 0.016 CID_154699902 | CID_154699902 | |
| 0.141 | 0.079 | 0.141 | Thiol protease inhibitor | |||
| 0.073 | 0.011 | 0.073 | Pregnane X receptor antagonist | |||
| 0.088 | 0.026 | 0.088 | Adenosine A1 receptor antagonist | 0.053 0.045 CID_154699902 | ||
| 0.066 | 0.005 | 0.066 | Kainate receptor 4 antagonist | |||
| 0.082 | 0.022 | 0.082 | Glutamate (mGluR1) antagonist | |||
| 0.066 | 0.006 | 0.066 | p53 inhibitor | |||
| 0.152 | 0.092 | 0.152 | CDC-like kinase 2 inhibitor | |||
| 0.077 | 0.017 | 0.1 | Carbonic anhydrase XIV inhibitor | 0.1 0.011 CID_154699902 | CID_154699902 | |
| 0.146 | 0.087 | 0.218 | Melanin inhibitor | 0.218 0.035 CID_154699902 | CID_154699902 | |
| 0.064 | 0.005 | 0.064 | Heme oxygenase inhibitor | |||
| 0.065 | 0.006 | 0.065 | 5-Alpha-reductase 1 inhibitor | |||
| 0.073 | 0.015 | 0.178 | Alpha-mannosidase inhibitor | 0.178 0.003 CID_154699902 | CID_154699902 | |
| 0.069 | 0.011 | 0.069 | Thymidine kinase inhibitor | 0.062 0.013 CID_154699902 | ||
| 0.067 | 0.009 | 0.067 | Somatostatin 5 antagonist | |||
| 0.061 | 0.004 | 0.061 | Retinoic acid receptor antagonist | |||
| 0.071 | 0.014 | 0.071 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.061 | 0.004 | 0.061 | Retinoic acid alpha receptor antagonist | |||
| 0.083 | 0.025 | 0.083 | Adrenaline uptake inhibitor | |||
| 0.076 | 0.019 | 0.076 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.078 | 0.021 | 0.078 | Sigma receptor antagonist | |||
| 0.066 | 0.009 | 0.066 | Geranyltranstransferase inhibitor | |||
| 0.07 | 0.013 | 0.07 | Adenosine deaminase inhibitor | 0.06 0.021 CID_154699902 | ||
| 0.064 | 0.007 | 0.064 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.061 | 0.005 | 0.061 | Retinoid X receptor antagonist | |||
| 0.064 | 0.009 | 0.064 | AMPA 2 receptor antagonist | |||
| 0.127 | 0.071 | 0.127 | Toll-Like receptor 2 antagonist | |||
| 0.092 | 0.036 | 0.092 | Estrogen-related receptor beta agonist | |||
| 0.058 | 0.003 | 0.058 | Retinoic acid beta receptor antagonist | |||
| 0.064 | 0.01 | 0.069 | Neuraminidase (Influenza A) inhibitor | 0.069 0.008 CID_154699902 | CID_154699902 | |
| 0.07 | 0.015 | 0.07 | Prolyl endopeptidase inhibitor | 0.059 0.025 CID_154699902 | ||
| 0.065 | 0.011 | 0.065 | Purinergic P2X4 antagonist | |||
| 0.059 | 0.005 | 0.059 | ATP citrate lysase inhibitor | |||
| 0.105 | 0.051 | 0.105 | Potassium channel (Ca-activated) activator | |||
| 0.074 | 0.02 | 0.074 | Sphingosine kinase inhibitor | |||
| 0.076 | 0.022 | 0.104 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.104 0.013 CID_154699902 | CID_154699902 | |
| 0.08 | 0.028 | 0.08 | Potassium channel (ATP-sensitive) blocker | |||
| 0.122 | 0.069 | 0.122 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.072 | 0.02 | 0.072 | Cyclin B2 inhibitor | |||
| 0.087 | 0.036 | 0.087 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.098 | 0.046 | 0.122 | Glutamate release inhibitor | 0.122 0.02 CID_154699902 | CID_154699902 | |
| 0.059 | 0.007 | 0.059 | Angiotensin AT1 receptor antagonist | |||
| 0.11 | 0.059 | 0.334 | AMP-activated protein kinase stimulant | 0.334 0.005 CID_154699902 | CID_154699902 | |
| 0.059 | 0.008 | 0.059 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.055 | 0.004 | 0.055 | Glutamate (mGluR3) agonist | |||
| 0.064 | 0.014 | 0.064 | Factor III inhibitor | 0.049 0.037 CID_154699902 | ||
| 0.085 | 0.036 | 0.085 | Prostaglandin-E synthase inhibitor | |||
| 0.059 | 0.01 | 0.059 | Nerve growth factor antagonist | |||
| 0.068 | 0.019 | 0.068 | Epithelial sodium channel blocker | |||
| 0.068 | 0.02 | 0.068 | Ryanodine receptor antagonist | |||
| 0.11 | 0.062 | 0.11 | Protein kinase C gamma inhibitor | |||
| 0.053 | 0.005 | 0.053 | Retinoid X alpha receptor antagonist | |||
| 0.181 | 0.133 | 0.618 | Hypoglycemic | 0.618 0.007 CID_154699902 | CID_154699902 | |
| 0.051 | 0.003 | 0.051 | Retinoic acid receptor gamma antagonist | |||
| 0.136 | 0.089 | 0.136 | Neuropeptide Y1 antagonist | |||
| 0.06 | 0.013 | 0.06 | Benzodiazepine antagonist | |||
| 0.056 | 0.01 | 0.056 | Beta adrenoreceptor agonist | |||
| 0.068 | 0.024 | 0.068 | Beta 2 adrenoreceptor agonist | |||
| 0.048 | 0.004 | 0.048 | Retinoic acid gamma receptor agonist | |||
| 0.055 | 0.012 | 0.055 | Farnesoid X receptor agonist | |||
| 0.148 | 0.105 | 0.148 | Neurotensin receptor agonist | |||
| 0.088 | 0.045 | 0.088 | Chymotrypsin inhibitor | |||
| 0.049 | 0.007 | 0.049 | Angiotensin II receptor antagonist | |||
| 0.11 | 0.068 | 0.252 | Monophenol monooxygenase inhibitor | 0.252 0.024 CID_154699902 | CID_154699902 | |
| 0.148 | 0.106 | 0.153 | DNA methyltransferase I inhibitor | 0.153 0.101 CID_154699902 | CID_154699902 | |
| 0.046 | 0.005 | 0.046 | Thymidine phosphorylase inhibitor | 0.029 0.014 CID_154699902 | ||
| 0.072 | 0.031 | 0.072 | TRPA1 antagonist | |||
| 0.063 | 0.023 | 0.063 | Leukotriene C antagonist | |||
| 0.049 | 0.008 | 0.049 | Glutamate (mGluR2) antagonist | |||
| 0.065 | 0.024 | 0.065 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.061 | 0.021 | 0.061 | CD45 antagonist | |||
| 0.049 | 0.009 | 0.049 | Glutamate (mGluR8) antagonist | |||
| 0.043 | 0.004 | 0.043 | Kainate receptor 3 antagonist | |||
| 0.053 | 0.015 | 0.053 | Dihydropteroate synthase inhibitor | |||
| 0.08 | 0.042 | 0.08 | Epoxide hydrolase inhibitor | |||
| 0.061 | 0.022 | 0.061 | Carbonic anhydrase II stimulant | |||
| 0.042 | 0.005 | 0.042 | Beta 1 adrenoreceptor agonist | |||
| 0.04 | 0.002 | 0.04 | Carbonic anhydrase XI inhibitor | |||
| 0.16 | 0.123 | 0.16 | Neurotrophic factor enhancer | 0.152 0.134 CID_154699902 | ||
| 0.065 | 0.028 | 0.065 | Bcl-xL inhibitor | |||
| 0.057 | 0.019 | 0.057 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.047 | 0.01 | 0.047 | Dipeptidyl peptidase II inhibitor | |||
| 0.041 | 0.005 | 0.041 | Prostaglandin H2 antagonist | |||
| 0.057 | 0.021 | 0.057 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.103 | 0.067 | 0.185 | Mediator release inhibitor | 0.185 0.017 CID_154699902 | CID_154699902 | |
| 0.043 | 0.007 | 0.043 | Prostaglandin EP1 antagonist | |||
| 0.063 | 0.027 | 0.063 | 5 Hydroxytryptamine 7 agonist | |||
| 0.04 | 0.005 | 0.04 | Retinoid X gamma receptor antagonist | |||
| 0.101 | 0.066 | 0.101 | Urease inhibitor | |||
| 0.084 | 0.049 | 0.084 | Glutamate receptor agonist | |||
| 0.046 | 0.011 | 0.046 | Prostaglandin agonist | |||
| 0.038 | 0.003 | 0.038 | CXC chemokine 5 receptor antagonist | |||
| 0.076 | 0.041 | 0.076 | HIV-1 integrase inhibitor | |||
| 0.042 | 0.008 | 0.042 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.065 | 0.031 | 0.065 | CDK4/cyclin D inhibitor | |||
| 0.137 | 0.104 | 0.137 | Mcl-1 antagonist | |||
| 0.037 | 0.005 | 0.04 | Vanilloid 2 agonist | 0.04 0.004 CID_154699902 | CID_154699902 | |
| 0.048 | 0.016 | 0.05 | Arginase inhibitor | 0.05 0.015 CID_154699902 | CID_154699902 | |
| 0.042 | 0.01 | 0.042 | Prostaglandin EP4 antagonist | |||
| 0.038 | 0.006 | 0.038 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.035 0.007 CID_154699902 | ||
| 0.035 | 0.004 | 0.035 | Retinoid X beta receptor antagonist | |||
| 0.21 | 0.179 | 0.21 | Calpain 2 inhibitor | |||
| 0.099 | 0.068 | 0.099 | MAP kinase kinase kinase inhibitor | |||
| 0.034 | 0.004 | 0.034 | Thyroid hormone alpha agonist | |||
| 0.037 | 0.006 | 0.037 | Prostaglandin EP4 agonist | |||
| 0.034 | 0.004 | 0.034 | Complement factor 1 inhibitor | |||
| 0.039 | 0.01 | 0.039 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.034 | 0.005 | 0.034 | Complement factor 1s inhibitor | |||
| 0.083 | 0.054 | 0.083 | Histamine H1 receptor antagonist | |||
| 0.037 | 0.008 | 0.037 | MAP3K8 inhibitor | |||
| 0.074 | 0.045 | 0.074 | Phospholipase D inhibitor | |||
| 0.033 | 0.004 | 0.033 | Neuraminidase (Influenza B) inhibitor | |||
| 0.075 | 0.047 | 0.075 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.165 | 0.137 | 0.526 | Vasodilator | 0.526 0.01 CID_154699902 | CID_154699902 | |
| 0.058 | 0.03 | 0.058 | Leukotriene B4 antagonist | 0.053 0.039 CID_154699902 | ||
| 0.066 | 0.038 | 0.066 | Kallikrein 7 inhibitor | |||
| 0.059 | 0.033 | 0.059 | Cyclin B inhibitor | |||
| 0.035 | 0.009 | 0.035 | Prostaglandin E2 agonist | |||
| 0.048 | 0.022 | 0.048 | Dihydrofolate reductase inhibitor | |||
| 0.03 | 0.004 | 0.03 | Carbonic anhydrase VIII inhibitor | |||
| 0.03 | 0.004 | 0.03 | Carbonic anhydrase X inhibitor | |||
| 0.122 | 0.097 | 0.122 | Cyclooxygenase inhibitor | 0.113 0.108 CID_154699902 | ||
| 0.038 | 0.012 | 0.038 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.03 | 0.004 | 0.03 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.127 | 0.102 | 0.127 | Heat shock protein 90 antagonist | |||
| 0.042 | 0.017 | 0.042 | Integrin alpha1beta1 antagonist | |||
| 0.03 | 0.006 | 0.03 | ICAM 1 antagonist | |||
| 0.123 | 0.099 | 0.144 | CC chemokine 6 receptor antagonist | 0.144 0.031 CID_154699902 | CID_154699902 | |
| 0.028 | 0.004 | 0.028 | Egl nine homolog 1 inhibitor | |||
| 0.038 | 0.014 | 0.038 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.028 | 0.005 | 0.028 | Nicotinic acid receptor 1 antagonist | |||
| 0.09 | 0.067 | 0.09 | Prolactin inhibitor | |||
| 0.053 | 0.031 | 0.053 | Urokinase inhibitor | |||
| 0.032 | 0.01 | 0.032 | Thyroid hormone agonist | |||
| 0.191 | 0.17 | 0.191 | Thyroid hormone antagonist | |||
| 0.042 | 0.021 | 0.042 | Leukotriene C4 antagonist | |||
| 0.075 | 0.055 | 0.075 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.024 | 0.005 | 0.024 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.029 | 0.01 | 0.029 | Glutamate (mGluR1) agonist | |||
| 0.036 | 0.018 | 0.036 | HCV polyprotein inhibitor | |||
| 0.122 | 0.105 | 0.122 | Acetylcholine M1 receptor antagonist | |||
| 0.065 | 0.048 | 0.065 | Leukotriene synthesis inhibitor | |||
| 0.059 | 0.042 | 0.059 | Heat shock protein 90 beta antagonist | |||
| 0.019 | 0.002 | 0.019 | Mannitol 2-dehydrogenase inhibitor | |||
| 0.041 | 0.024 | 0.041 | CF transmembrane conductance regulator antagonist | |||
| 0.035 | 0.019 | 0.035 | Melatonin receptor 1A agonist | |||
| 0.096 | 0.08 | 0.096 | Factor V inhibitor | |||
| 0.02 | 0.004 | 0.02 | Glutamate (mGluR6) agonist | |||
| 0.068 | 0.052 | 0.07 | Protein kinase C beta inhibitor | 0.07 0.049 CID_154699902 | CID_154699902 | |
| 0.135 | 0.12 | 0.135 | Tumour necrosis factor antagonist | |||
| 0.026 | 0.011 | 0.026 | Glutamate (mGluR1a) agonist | |||
| 0.021 | 0.005 | 0.021 | Angiotensin AT1B receptor antagonist | |||
| 0.035 | 0.021 | 0.035 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.022 | 0.007 | 0.022 | Adenosine A3 receptor agonist | 0.019 0.01 CID_154699902 | ||
| 0.049 | 0.035 | 0.049 | Potassium channel (Inward rectifier) blocker | |||
| 0.028 | 0.013 | 0.028 | Prostaglandin EP2 agonist | |||
| 0.086 | 0.071 | 0.086 | Breast cancer-resistant protein inhibitor | |||
| 0.048 | 0.034 | 0.048 | Dopamine beta hydroxylase inhibitor | |||
| 0.026 | 0.012 | 0.026 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.024 | 0.01 | 0.024 | 5-Alpha-reductase 2 inhibitor | |||
| 0.123 | 0.109 | 0.3 | Hemostatic | 0.3 0.016 CID_154699902 | CID_154699902 | |
| 0.019 | 0.005 | 0.019 | Beta 3 adrenoreceptor agonist | |||
| 0.027 | 0.014 | 0.027 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.024 | 0.011 | 0.024 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.033 | 0.02 | 0.033 | Cholesterol ester transfer protein antagonist | |||
| 0.02 | 0.007 | 0.02 | Thyroid hormone alpha antagonist | |||
| 0.165 | 0.152 | 0.165 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.257 | 0.245 | 0.372 | Caspase 9 stimulant | 0.372 0.129 CID_154699902 | CID_154699902 | |
| 0.031 | 0.019 | 0.031 | Caspase 6 inhibitor | |||
| 0.022 | 0.01 | 0.022 | Caspase 8 inhibitor | |||
| 0.036 | 0.024 | 0.036 | AMPA receptor agonist | |||
| 0.015 | 0.003 | 0.015 | DNA topoisomerase III inhibitor | |||
| 0.061 | 0.049 | 0.061 | Leukotriene antagonist | |||
| 0.045 | 0.034 | 0.045 | Carbonic anhydrase VII inhibitor | |||
| 0.036 | 0.025 | 0.036 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.028 | 0.017 | 0.028 | Glucosylceramidase stimulant | |||
| 0.11 | 0.1 | 0.11 | Alkaline phosphatase inhibitor | |||
| 0.029 | 0.019 | 0.029 | Leukotriene B4 receptor 1 antagonist | |||
| 0.033 | 0.023 | 0.033 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.097 | 0.089 | 0.221 | DNA polymerase I inhibitor | 0.221 0.022 CID_154699902 | CID_154699902 | |
| 0.044 | 0.035 | 0.044 | Endothelin-converting enzyme inhibitor | |||
| 0.085 | 0.076 | 0.085 | ABCA1 expression enhancer | |||
| 0.027 | 0.019 | 0.027 | Protocollagen prolyl hydroxylase inhibitor | |||
| 0.022 | 0.014 | 0.022 | Angiotensin AT1A receptor antagonist | |||
| 0.033 | 0.025 | 0.033 | Free fatty acid receptor 1 antagonist | |||
| 0.038 | 0.03 | 0.038 | Dopamine D5 agonist | |||
| 0.028 | 0.02 | 0.028 | DNA polymerase III inhibitor | |||
| 0.046 | 0.039 | 0.046 | Topoisomerase II beta inhibitor | |||
| 0.03 | 0.023 | 0.03 | Cyclophilin A inhibitor | |||
| 0.022 | 0.015 | 0.022 | Adenosine kinase inhibitor | |||
| 0.041 | 0.035 | 0.041 | Purinergic P2Y antagonist | |||
| 0.018 | 0.012 | 0.018 | Aminopeptidase A inhibitor | |||
| 0.017 | 0.01 | 0.017 | Adenosine A2 receptor agonist | 0.015 0.013 CID_154699902 | ||
| 0.013 | 0.007 | 0.013 | Egl nine homolog 3 inhibitor | |||
| 0.143 | 0.138 | 0.143 | Anticonvulsant | |||
| 0.021 | 0.016 | 0.021 | Melanocortin 5 agonist | |||
| 0.051 | 0.046 | 0.051 | DNA helicase inhibitor | |||
| 0.015 | 0.01 | 0.015 | Adenosine A2a receptor agonist | |||
| 0.124 | 0.12 | 0.124 | Heat shock protein 90 alpha antagonist | |||
| 0.041 | 0.037 | 0.041 | Oleamide hydrolase inhibitor | |||
| 0.046 | 0.043 | 0.108 | Aldose reductase inhibitor | 0.108 0.016 CID_154699902 | CID_154699902 | |
| 0.113 | 0.109 | 0.113 | Cytidine deaminase inhibitor | |||
| 0.04 | 0.037 | 0.04 | Sphingosine 1-phosphate receptor agonist | |||
| 0.034 | 0.031 | 0.034 | Integrin alpha2 antagonist | |||
| 0.025 | 0.021 | 0.025 | Lysine carboxypeptidase inhibitor | |||
| 0.031 | 0.028 | 0.031 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.01 | 0.007 | 0.017 | Purinergic P2Y2 agonist | 0.017 0.003 CID_154699902 | CID_154699902 | |
| 0.025 | 0.022 | 0.025 | Integrin alpha2beta1 antagonist | |||
| 0.066 | 0.063 | 0.066 | Acetylcholine M4 receptor antagonist | |||
| 0.031 | 0.029 | 0.031 | Carnitine palmitoyltransferase inhibitor | |||
| 0.018 | 0.017 | 0.018 | Angiotensin AT2 receptor antagonist | |||
| 0.012 | 0.011 | 0.012 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.065 | 0.065 | 0.107 | Na+ K+ transporting ATPase inhibitor | 0.107 0.025 CID_154699902 | CID_154699902 | |
| 0.196 | 0.196 | 0.506 | Interleukin 2 agonist | 0.506 0.007 CID_154699902 | CID_154699902 | |
| 0.016 | 0.015 | 0.023 | Telomerase stimulant | 0.023 0.005 CID_154699902 | CID_154699902 | |
| 0.052 | 0.052 | 0.052 | Acetyl-CoA transferase 2 inhibitor | 0.052 0.05 CID_154699902 | CID_154699902 | |
| 0.02 | 0.021 | 0.026 | Adenosine A1 receptor agonist | 0.026 0.014 CID_154699902 | CID_154699902 | |
| 0.001 | 0.004 | 0.004 | Purinergic P2Y6 agonist | 0.004 0.002 CID_154699902 | CID_154699902 | |
| 0.023 | 0.027 | 0.102 | Sodium/glucose cotransporter 2 inhibitor | 0.102 0.003 CID_154699902 | CID_154699902 | |
| 0.016 | 0.022 | 0.035 | Antibiotic Anthracycline-like | 0.035 0.003 CID_154699902 | CID_154699902 | |
| 0.092 | 0.099 | 0.213 | Alkylator | 0.213 0.023 CID_154699902 | CID_154699902 | |
| 0.029 | 0.045 | 0.036 | Protein kinase C beta I inhibitor | 0.036 0.015 CID_154699902 | CID_154699902 | |
| 0.021 | 0.038 | 0.089 | Sodium/glucose cotransporter inhibitor | 0.089 0.003 CID_154699902 | CID_154699902 | |
| 0.122 | 0.145 | 0.142 | Psychostimulant | 0.142 0.124 CID_154699902 | CID_154699902 | |
| 0.005 | 0.034 | 0.013 | Purinergic P2 agonist | 0.013 0.012 CID_154699902 | CID_154699902 | |
| 0.005 | 0.034 | 0.013 | Purinergic receptor agonist | 0.013 0.012 CID_154699902 | CID_154699902 | |
| 0.02 | 0.056 | 0.041 | Toll-Like receptor 4 agonist | 0.041 0.005 CID_154699902 | CID_154699902 | |
| 0.013 | 0.051 | 0.044 | Squalene synthetase inhibitor | 0.044 0.016 CID_154699902 | CID_154699902 | |
| 0.068 | 0.108 | 0.229 | Transcription factor NF kappa B stimulant | 0.229 0.007 CID_154699902 | CID_154699902 | |
| 0.034 | 0.104 | 0.093 | Glucose-6-phosphate translocase inhibitor | 0.093 0.007 CID_154699902 | CID_154699902 | |
| 0.072 | 0.143 | 0.133 | Multidrug resistance-associated protein 1 inhibitor | 0.133 0.036 CID_154699902 | CID_154699902 | |
| 0.072 | 0.144 | 0.109 | Phosphodiesterase 6D inhibitor | 0.109 0.037 CID_154699902 | CID_154699902 | |
| 0.122 | 0.205 | 0.672 | Antioxidant | 0.672 0.007 CID_154699902 | CID_154699902 | |
| 0.107 | 0.196 | 0.297 | Hypolipemic | 0.297 0.05 CID_154699902 | CID_154699902 | |
| 0.042 | 0.142 | 0.067 | Lipocortins synthesis agonist | 0.067 0.024 CID_154699902 | CID_154699902 | |
| 0.024 | 0.126 | 0.063 | Microtubule stabilization | 0.063 0.011 CID_154699902 | CID_154699902 | |
| 0.008 | 0.11 | 0.018 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.018 0.009 CID_154699902 | CID_154699902 | |
| 0.027 | 0.129 | 0.123 | Protein kinase C eta inhibitor | 0.123 0.012 CID_154699902 | CID_154699902 | |
| 0.135 | 0.243 | 0.393 | Peptidyltransferase inhibitor | 0.393 0.007 CID_154699902 | CID_154699902 | |
| 0.087 | 0.205 | 0.307 | NOS3 expression enhancer | 0.307 0.017 CID_154699902 | CID_154699902 | |
| 0.007 | 0.127 | 0.022 | Corticosteroid-like | 0.022 0.013 CID_154699902 | CID_154699902 | |
| 0.067 | 0.211 | 0.252 | Cell adhesion inhibitor | 0.252 0.015 CID_154699902 | CID_154699902 | |
| 0.024 | 0.179 | 0.047 | Cytokine production stimulant | 0.047 0.039 CID_154699902 | CID_154699902 | |
| 0.026 | 0.182 | 0.084 | Factor IXa inhibitor | 0.084 0.014 CID_154699902 | CID_154699902 | |
| 0.055 | 0.211 | 0.353 | Lipid peroxidase inhibitor | 0.353 0.013 CID_154699902 | CID_154699902 | |
| 0.056 | 0.215 | 0.309 | Thrombolytic | 0.309 0.022 CID_154699902 | CID_154699902 | |
| 0.016 | 0.213 | 0.208 | Antineoplastic antibiotic | 0.208 0.02 CID_154699902 | CID_154699902 | |
| 0.037 | 0.237 | 0.161 | Topoisomerase II inhibitor | 0.161 0.044 CID_154699902 | CID_154699902 | |
| 0.009 | 0.214 | 0.066 | Protein 30S ribosomal subunit inhibitor | 0.066 0.005 CID_154699902 | CID_154699902 | |
| 0.007 | 0.227 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.023 CID_154699902 | CID_154699902 | |
| 0.033 | 0.258 | 0.127 | DNA intercalator | 0.127 0.054 CID_154699902 | CID_154699902 | |
| 0.026 | 0.268 | 0.272 | Topoisomerase I inhibitor | 0.272 0.014 CID_154699902 | CID_154699902 | |
| 0.065 | 0.309 | 0.311 | Platelet antagonist | 0.311 0.049 CID_154699902 | CID_154699902 | |
| 0.001 | 0.253 | 0.013 | Antibiotic Macrolide-like | 0.013 0.01 CID_154699902 | CID_154699902 | |
| 0.049 | 0.302 | 0.271 | Anticoagulant | 0.271 0.034 CID_154699902 | CID_154699902 | |
| 0.056 | 0.333 | 0.502 | Nitric oxide antagonist | 0.502 0.016 CID_154699902 | CID_154699902 | |
| 0.053 | 0.36 | 0.507 | Platelet adhesion inhibitor | 0.507 0.005 CID_154699902 | CID_154699902 | |
| 0.05 | 0.387 | 0.161 | P-glycoprotein inhibitor | 0.161 0.101 CID_154699902 | CID_154699902 | |
| 0.036 | 0.384 | 0.181 | Toll-Like receptor 4 antagonist | 0.181 0.009 CID_154699902 | CID_154699902 | |
| 0.014 | 0.385 | 0.079 | Antibiotic Aminoglycoside-like | 0.079 0.004 CID_154699902 | CID_154699902 | |
| 0.014 | 0.388 | 0.068 | Nitric oxide donor | 0.068 0.035 CID_154699902 | CID_154699902 | |
| 0.022 | 0.415 | 0.116 | Cell adhesion molecule inhibitor | 0.116 0.026 CID_154699902 | CID_154699902 | |
| 0.055 | 0.465 | 0.49 | Immunosuppressant | 0.49 0.036 CID_154699902 | CID_154699902 | |
| 0.011 | 0.422 | 0.11 | Protein 50S ribosomal subunit inhibitor | 0.11 0.011 CID_154699902 | CID_154699902 | |
| 0.042 | 0.454 | 0.256 | Insulin secretagoues | 0.256 0.018 CID_154699902 | CID_154699902 | |
| 0.042 | 0.463 | 0.318 | Alpha-glucosidase inhibitor | 0.318 0.151 CID_154699902 | CID_154699902 | |
| 0.011 | 0.462 | 0.087 | Protein kinase A inhibitor | 0.087 0.055 CID_154699902 | CID_154699902 | |
| 0.011 | 0.601 | 0.1 | Topoisomerase II alpha inhibitor | 0.1 0.04 CID_154699902 | CID_154699902 | |
| 0.019 | 0.72 | 0.23 | Angiogenesis inhibitor | 0.23 0.139 CID_154699902 | CID_154699902 | |
| 0.021 | 0.794 | 0.434 | Immunomodulator | 0.434 0.035 CID_154699902 | CID_154699902 | |
| 0.006 | 0.878 | 0.423 | Tumour necrosis factor alpha release inhibitor | 0.423 0.023 CID_154699902 | CID_154699902 | |
| 0.019 | 0.917 | 0.297 | Caspase 3 stimulant | 0.297 0.08 CID_154699902 | CID_154699902 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |